Skip to main content
. 2016 Apr 29;59(11):5416–5431. doi: 10.1021/acs.jmedchem.6b00275

Figure 1.

Figure 1

Structures of selected triazolopyrimidine PfDHODH inhibitors. Shown structures include, 2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-λ6-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine (1), (5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)naphthalen-2-ylamine (2), and (5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)(4-trifluoromethylphenyl)amine (3).